24. Schedule of Cash Flow, Supplemental Disclosures (Tables)

12 Months Ended

Dec. 31, 2015

Schedule Of Cash Flow Supplemental Disclosures Tables

Schedule of cash flow, supplemental disclosures

Note 24. Supplemental Cash Flow Information

		Years ended December 31,
		2015		2014		2013
Supplemental disclosures of Cash Flow Information:
Cash (received) paid for income taxes, net	$	(352)	$	4,217	$	1,265
Cash paid for interest		30,207		6,451		2,733
Supplemental disclosures of Non-cash Investing and Financing Activities:
Conversion of 8.00% Convertible notes		60,172		-		-
Issuance of 1,682,086 shares to Zogenix for Zohydro acquisition		11,926		-		-
Acquisition of TREXIMET® - warrants issued to Pozen		-		2,359		-
Accrued severance paid in restricted common stock		-		-		142
Acquisition of Cypress and Somaxon - Purchase price adjustment		-		(990)		5,412
Acquisition of Somaxon - Fair value of common stock		-		-		24,840
Warrants issued to Frontline in connection with the issuance of the
8% Convertible Notes		-		841		-
Acquisition of license - contract payable		-		-		500